NCT03586531

Brief Summary

Patients presented with unexplained elevated serum creatinine including vast varieties of acute or chronic kidney disease. Renal biopsy may include acute and chronic interstitial nephritis, glomerulosclerosis and tubular atrophy, acute tubular necrosis, rapidly progressive glomerulonephritis, granulomatous glomerulonephritis, monoclonal gammopathy, myeloma kidney or thrombotic microangiopathy . Renal biopsy definitely still plays the most vital and irreplaceable role in the investigations of cases with unexplained renal impairment. Despite a vastly variable biopsy results between patients, renal biopsy has helped in determining the best treatment and prognosis for the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2018

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 19, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 13, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

July 19, 2023

Status Verified

July 1, 2023

Enrollment Period

3 years

First QC Date

June 19, 2018

Last Update Submit

July 18, 2023

Conditions

Keywords

renal biopsy, CKDu Egypt, unexplained elevated serum creatinine

Outcome Measures

Primary Outcomes (1)

  • correlation between histopathological findings and serum creatinine in umol/l

    histopathological patterns in term of glomerlular pathology, interstitial fibrosis, tubular injury and serum creatinine in umol /l

    3 years

Interventions

renal biopsyPROCEDURE

Renal biopsy samples will be obtained by a percutaneous method using a spring-loaded Trucut® biopsy needle under real time ultrasound guidance. Biopsy samples will be processed for light microscopy with special staining will be done: Schiff periodic acid, Masson trichrome and methenamine silver.and immunofluorescence studies to evaluate IgA, IgG, IgM, complement C1q and C3, fibrin, and kappa and lambda light chain deposits.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients attended to outpatient clinics or admitted to internal medicine department in assiut univesity hospital

You may qualify if:

  • Impaired renal function (serum creatinine\> 115umol/l serum urea \> 8 mmol/l)
  • Negative immunological markers i.e ANA, ANCA, cryoglobulin, and complement level.

You may not qualify if:

  • Diabetic patients.
  • Hypertensive patients.
  • All causes of Acute kidney injury
  • Bleeding diathesis.
  • Known cases of primary or secondary glomerulonephritis.
  • Patients with a single functioning kidney
  • small sized kidneys
  • Multiple renal cysts and ADPKD.
  • Patients with asymmetrical kidney size.
  • Patient with active infections.
  • HBsAg, HCV and HIV positive patients.
  • Obstructive uropathy.
  • Patients with active malignancies e.g multiple myeloma
  • Renal transplant.
  • Refusal to do a biopsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospital

Asyut, 71515, Egypt

Location

Related Publications (1)

  • Ellisy RA, Tony EA, Ismail W, Radi R, Seddik MI, Abdel Aziz EM. Clinicopathological characteristics and outcomes of patients with unexplained renal impairment: A single center study. Nefrologia (Engl Ed). 2025 Mar;45(3):249-258. doi: 10.1016/j.nefroe.2025.02.012.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Renal biopsy spicemin retained in diluted formaldyde

MeSH Terms

Conditions

Renal Insufficiency

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 19, 2018

First Posted

July 13, 2018

Study Start

June 13, 2018

Primary Completion

May 31, 2021

Study Completion

May 1, 2022

Last Updated

July 19, 2023

Record last verified: 2023-07

Locations